Characterization of the lipid and protein organization in HBsAg viral particles by steady-state and time-resolved fluorescence spectroscopy

Biochimie

Volumn 92, Issue 8, 2010, Pages 994-1002

  Greiner, Vanille J ^a   Egelé, Caroline ^a   Oncul, Sule ^a   Ronzon, Frédéric ^b   Manin, Catherine ^b   Klymchenko, Andrey ^a   Mely Yves Y ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b SANOFI PASTEUR   (France)

Author keywords

Fluorescence spectroscopy; Fluorescent probes; HBsAg viral particles; Lipid membranes; Low density lipoprotein

Indexed keywords

1,6 DIPHENYL 1,3,5 HEXATRIENE; 3 HYDROXYFLAVONE; FATTY ACID; HEPATITIS B SURFACE ANTIGEN; LIPID; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; TRYPTOPHAN; VITRONECTIN;

ALPHA HELIX; ARTICLE; CELL POLARITY; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; HYDROPHOBICITY; LIPID ANALYSIS; LIPID COMPOSITION; LIPID MEMBRANE; LIPID VESICLE; NONHUMAN; PHOSPHOLIPID MEMBRANE; PICHIA ANGUSTA; PROTEIN ANALYSIS; PROTEIN STRUCTURE; STEADY STATE; VIRUS PARTICLE; VISCOSITY;

FLUORESCENT DYES; HEPATITIS B SURFACE ANTIGENS; LIPIDS; SPECTROMETRY, FLUORESCENCE; VIRAL PROTEINS;

PICHIA ANGUSTA;

EID: 77954657585     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.04.014     Document Type: Article

References (59)

1. Ganem D., Varmus H.E. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 1987, 56:651-693.
2. Robinson W.S., Lutwick L.I. The virus of hepatitis, type B (first of two parts). N. Engl. J. Med. 1976, 295:1168-1175.
3. Bayer M.E., Blumberg B.S., Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's syndrome and hepatitis. Nature 1968, 218:1057-1059.
4. Sutnick A.I., London W.T., Blumberg B.S. Australia antigen and the quest for a hepatitis virus. Am. J. Dig. Dis. 1969, 14:189-194.
5. Hirschman R.J., Shulman N.R., Barker L.F., Smith K.O. Virus-like particles in sera of patients with infectious and serum hepatitis. JAMA 1969, 208:1667-1670.
6. Dane D.S., Cameron C.H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970, 1:695-698.
7. Gavilanes F., Gomez-Gutierrez J., Aracil M., Gonzalez-Ros J.M., Ferragut J.A., Guerrero E., Peterson D.L. Hepatitis B surface antigen. Role of lipids in maintaining the structural and antigenic properties of protein components. Biochem. J. 1990, 265:857-864.
8. McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R. Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307:178-180.
9. Maupas P., Goudeau A., Coursaget P., Drucker J., Bagros P. Immunisation against hepatitis B in man. Lancet 1976, 1:1367-1370.
10. Gomez-Gutierrez J., Rodriguez-Crespo I., Peterson D.L., Gavilanes F. Antigenicity of hepatitis B surface antigen proteins reconstituted with phospholipids. Biochim. Biophys. Acta 1995, 1233:205-212.
11. Diminsky D., Moav N., Gorecki M., Barenholz Y. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles. Vaccine 1999, 18:3-17.
12. Satoh O., Imai H., Yoneyama T., Miyamura T., Utsumi H., Inoue K., Umeda M. Membrane structure of the hepatitis B virus surface antigen particle. J. Biochem. 2000, 127:543-550.
13. Gilbert R.J., Beales L., Blond D., Simon M.N., Lin B.Y., Chisari F.V., Stuart D.I., Rowlands D.J. Hepatitis B small surface antigen particles are octahedral. Proc Natl Acad Sci U S A 2005, 102:14783-14788.
14. Diminsky D., Schirmbeck R., Reimann J., Barenholz Y. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 1997, 15:637-647.
15. Bruss V., Ganem D. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci U S A 1991, 88:1059-1063.
16. Gavilanes F., Gonzalez-Ros J.M., Peterson D.L. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J. Biol. Chem. 1982, 257:7770-7777.
17. Guerrero E., Gavilanes F., Peterson D.L. Model for the protein arrangement in HBsAg particles based on physical and chemical studies. Viral Hepatitis and Liver Disease 1988, 606-613. Alan R Liss Inc., New York. A.J. Zuckerman (Ed.).
18. Lentz B.R. Membrane 'fluidity' as detected by diphenylhexatriene probes. Chem. Phys. Lipids 1989, 50:171.
19. Lentz B.R. Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem. Phys. Lipids 1993, 64:99-116.
20. Diaz G., Melis M., Batetta B., Angius F., Falchi A.M. Hydrophobic characterization of intracellular lipids in situ by Nile Red red/yellow emission ratio. Micron 2008, 39:819-824.
21. Greenspan P., Mayer E.P., Fowler S.D. Nile Red: a selective fluorescent stain for intracellular lipid droplets. J. Cell. Biol. 1985, 100:965-973.
22. Demchenko A.P., Mely Y., Duportail G., Klymchenko A.S. Monitoring biophysical properties of lipid membranes by environment-sensitive fluorescent probes. Biophys. J. 2009, 96:3461-3470.
23. Klymchenko A.S., Mely Y., Demchenko A.P., Duportail G. Simultaneous probing of hydration and polarity of lipid bilayers with 3-hydroxyflavone fluorescent dyes. Biochim. Biophys. Acta 2004, 1665:6-19.
24. Ozturk T., Klymchenko A.S., Capan A., Oncul S., Cikrikci S., Taskiran S., Tasan B., Kaynak F.B., Ozbey S., Demchenko A.P. New 3-hydroxyflavone derivatives for probing hydrophobic sites in microheterogeneous systems. Tetrahedron 2007, 63:10290-10299.
25. Klymchenko A.S., Duportail G., Ozturk T., Pivovarenko V.G., Mely Y., Demchenko A.P. Novel two-band ratiometric fluorescence probes with different location and orientation in phospholipid membranes. Chem. Biol. 2002, 9:1199-1208.
26. Shynkar V.V., Klymchenko A.S., Duportail G., Demchenko A.P., Mely Y. Two-color fluorescent probes for imaging the dipole potential of cell plasma membranes. Biochim. Biophys. Acta 2005, 1712:128-136.
27. Eisinger J., Navon G. Fluorescence quenching and isotope effect of tryptophan. J. Chem. Phys. 1969, 50:2069-2077.
28. Bombarda E., Ababou A., Vuilleumier C., Gerard D., Roques B.P., Piemont E., Mely Y. Time-resolved fluorescence investigation of the human immunodeficiency virus type 1 nucleocapsid protein: influence of the binding of nucleic acids. Biophys. J. 1999, 76:1561-1570.
29. Mely Y., Jullian N., Morellet N., De Rocquigny H., Dong C.Z., Piemont E., Roques B.P., Gerard D. Spatial proximity of the HIV-1 nucleocapsid protein zinc fingers investigated by time-resolved fluorescence and fluorescence resonance energy transfer. Biochemistry 1994, 33:12085-12091.
30. Livesey A.K., Brochon J.C. Analyzing the distribution of decay constants in pulse-fluorimetry using the maximum entropy method. Biophys. J. 1987, 52:693-706.
31. Azoulay J., Clamme J.P., Darlix J.L., Roques B.P., Mely Y. Destabilization of the HIV-1 complementary sequence of TAR by the nucleocapsid protein through activation of conformational fluctuations. J. Mol. Biol. 2003, 326:691-700.
32. Clamme J.P., Azoulay J., Mely Y. Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectroscopy. Biophys. J. 2003, 84:1960-1968.
33. Thompson N.L. Fluorescence correlation spectroscopy. Topics in Fluorescence Spectroscopy 1991, vol. 1. Plenum Press, New York. J.R. Lakowicz (Ed.).
34. Didier P., Godet J., Mely Y. Two-photon two-focus fluorescence correlation spectroscopy with a tunable distance between the excitation volumes. J. Fluoresc. 2009, 19:561-565.
35. Zhao Q., Wang Y., Freed D., Fu T.M., Gimenez J.A., Sitrin R.D., Washabaugh M.W. Maturation of recombinant hepatitis B virus surface antigen particles. Hum. Vaccin. 2006, 2:174-180.
36. Lakowicz J.R. Principles of Fluorescence Spectroscopy 1999, Academic/Plenum Publishers, New York. second ed.
37. Eftink M.R. Fluorescence quenching: theory and applications. Topics in Fluorescence Spectroscopy 1991, vol. 2. Plenum Press, New York. J.R. Lakowicz (Ed.).
38. Lehrer S.S. Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion. Biochemistry 1971, 10:3254-3263.
39. Siemiarczuk A., Wagner B.D., Ware W.R. Comparison of the maximum entropy and exponential series methods for the recovery of distributions of lifetimes from fluorescence lifetime data. J. Phys. Chem. 1990, 94:1661-1666.
40. Stryjewski W., Wasylewski Z. The resolution of heterogeneous fluorescence of multitryptophan-containing proteins studied by a fluorescence-quenching method. Eur. J. Biochem. 1986, 158:547-553.
41. Stirk H.J., Thornton J.M., Howard C.R. A topological model for hepatitis B surface antigen. Intervirology 1992, 33:148-158.
42. Villain M., Jackson P.L., Manion M.K., Dong W.J., Su Z., Fassina G., Johnson T.M., Sakai T.T., Krishna N.R., Blalock J.E. De novo design of peptides targeted to the EF hands of calmodulin. J. Biol. Chem. 2000, 275:2676-2685.
43. Raja C., Ferner J., Dietrich U., Avilov S., Ficheux D., Darlix J.L., de Rocquigny H., Schwalbe H., Mely Y. A tryptophan-rich hexapeptide inhibits nucleic acid destabilization chaperoned by the HIV-1 nucleocapsid protein. Biochemistry 2006, 45:9254-9265.
44. Dreesman G.R., Hollinger F.B., Suriano J.R., Fujioka R.S., Brunschwig J.P., Melnick J.L. Biophysical and biochemical heterogeneity of purified hepatitis B antigen. J. Virol. 1972, 10:469-476.
45. Mangold C.M., Streeck R.E. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J. Virol. 1993, 67:4588-4597.
46. Cooreman M.P., Leroux-Roels G., Paulij W.P. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J. Biomed. Sci. 2001, 8:237-247.
47. Moens P.D., Helms M.K., Jameson D.M. Detection of tryptophan to tryptophan energy transfer in proteins. Protein J. 2004, 23:79-83.
48. Sonveaux N., Thines D., Ruysschaert J.M. Characterization of the HBsAg particle lipid membrane. Res. Virol. 1995, 146:43-51.
49. Segrest J.P., Jones M.K., De Loof H., Dashti N. Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid. Res. 2001, 42:1346-1367.
50. Prassl R., Laggner P. Molecular structure of low density lipoprotein: current status and future challenges. Eur. Biophys. J. 2009, 38:145-158.
51. Morales N.P., Charlermchoung C., Luechapudiporn R., Yamanont P., Fucharoen S., Chantharaksri U. Lipid fluidity at different regions in LDL and HDL of beta-thalassemia/Hb E patients. Biochem. Biophys. Res. Commun. 2006, 350:698-703.
52. Hevonoja T., Pentikainen M.O., Hyvonen M.T., Kovanen P.T., Ala-Korpela M. Structure of low density lipoprotein (LDL) particles: basis for understanding molecular changes in modified LDL. Biochim. Biophys. Acta 2000, 1488:189-210.
53. Li Q.T., Tilley L., Sawyer W.H., Looney F., Curtain C.C. Structure and dynamics of microemulsions which mimic the lipid phase of low-density lipoproteins. Biochim. Biophys. Acta 1990, 1042:42-50.
54. Massey J.B., Pownall H.J. Surface properties of native human plasma lipoproteins and lipoprotein models. Biophys. J. 1998, 74:869-878.
55. Greenspan P., Lou P. Spectrofluorometric studies of nile red treated native and oxidized low density lipoprotein. Int. J. Biochem. 1993, 25:987-991.
56. Morrisett J.D., Jackson R.L., Gotto A.M. Lipoproteins: structure and function. Annu. Rev. Biochem. 1975, 44:183-207.
57. Klymchenko A.S., Duportail G., Demchenko A.P., Mely Y. Bimodal distribution and fluorescence response of environment-sensitive probes in lipid bilayers. Biophys. J. 2004, 86:2929-2941.
58. Finer E.G., Henry R., Leslie R.B., Robertson R.N. NMR studies of pig low- and high-density serum lipoproteins. Molecular motions and morphology. Biochim. Biophys. Acta 1975, 380:320-327.
59. Aggerbeck L.P., Peterson D.L. Electron microscopic and solution X-ray scattering observations on the structure of hepatitis B surface antigen. Virology 1985, 141:155-161.